You just read:

Two New Real-World Studies Confirm Positive Efficacy and Safety Profile of XARELTO® (rivaroxaban) in Treating and Preventing Blood Clots

News provided by

Janssen Pharmaceuticals, Inc.

Oct 23, 2016, 19:30 ET